HELP insiders bought $9.7M of stock. Now the borrow market is tightening.

Three signals on HELP are pointing in the same direction at once. The cost to borrow has jumped 264% in a week. Options positioning has hit a 52-week extreme. And short interest has just fallen 17% in a single day, even as borrowing costs spike.

Insiders Laid the Groundwork

The most striking fact in the HELP data is not the borrow market. It is what executives did in September.

CEO Michael Halstead bought 100,000 shares at $13.47 on September 21, spending $1.35 million of his own money. Executive Chair Eric So made three open-market purchases across September, totalling 295,000 shares and roughly $3.57 million. Chief Growth Officer Paul Glavine bought 300,000 shares across two September sessions for around $3.67 million. CFO Greg Cavers added 3,000 shares on September 29.

None of these trades were under a pre-arranged 10b5-1 plan. Combined, insiders spent $9.67 million in the 90 days to September 30, per ORTEX data sourced from SEC EDGAR Form 4 filings. So and Glavine subsequently filed Schedule 13D disclosures, each reporting a 5.8% stake as last disclosed on September 9. Both are now among the largest shareholders on the register. Schedule 13D positions are event-driven disclosures around the 5% threshold; stakes are "as last disclosed" and holders dropping below 5% may exit without a further filing.

The stock is now trading at $10.36, below every one of those purchase prices.

Borrow Costs Spike Into Earnings

Against that backdrop, the lending market has turned notably more expensive this week. The cost to borrow reached 3.01% on October 26, up 264% in a week from 0.83% on October 19. That said, availability remains very loose at 1,699%: for every share currently borrowed, roughly 17 more are sitting available in the lending pool. The spike in cost is not being driven by a shortage of supply. It reflects a jump in demand for borrows, even as short interest itself fell 17.3% on October 26 to 6.1% of free float.

The cost to borrow history shows this is not unprecedented for HELP. It traded above 5% in early October and touched 7% on October 5 before collapsing to 0.20% by October 22. The current spike looks like a repeat pattern rather than a structural shift.

Options Traders Turn Bullish

The options market is sending a clear directional signal. The put-to-call ratio hit 0.33 on October 26, a 52-week high, with a z-score of 3.0 relative to the 20-day average of 0.15. That reading means call buyers are unusually dominant. The ratio has been rising since October 22, when it stood at 0.11.

Earnings are scheduled for November 13. The company's lead drug, HLP003, is approaching a Phase 3 readout in Q4 2026 with enrollment above 88%. Wells Fargo raised its target to $22 on October 22. TD Cowen has a $62 target. The mean analyst target of $57 sits far above the current $10.36 price, though the stock is down 18% over the past month.

Data Summary

• Insider open-market buying (90 days, no 10b5-1 plans): $9.67 million net, per SEC EDGAR
• CEO, Executive Chair, Chief Growth Officer and CFO all bought in September
• Cost to borrow: 3.01%, up 264% in one week
• Availability: 1,699% (loose, ample supply)
• Short interest: 6.1% of free float, down 17.3% in one day
• Options PCR: 0.33, 52-week high, z-score of 3.0 vs 20-day average
• Next earnings: November 13, 2026 (17 days)
• Wells Fargo raised target to $22 on October 22; TD Cowen target $62